Advertisement

Evolution of gastrectomy for cancer over 30-years: Changes in presentation, management, and outcomes

Published:March 02, 2021DOI:https://doi.org/10.1016/j.surg.2021.01.040

      Abstract

      Background

      Gastric cancer has seen a considerable change in management, and outcomes for the past 30 years. Historically, the overall prognosis has been regarded as poor. However, the use of multimodal treatment, and integration of enhanced recovery pathways have improved short and long-term outcomes. The aim of this study was to evaluate the changing trends in presentation, management, and outcomes for patients undergoing surgical treatment for gastric cancers over 30 years.

      Methods

      Data from consecutive patients undergoing gastrectomy with curative intent for gastric adenocarcinoma between 1989 and 2018 from a single-center, high-volume unit were reviewed. Presentation method, management strategies and outcomes were reviewed. Patients were grouped into successive 5-year cohorts for comparison and evaluation of changing trends.

      Results

      Between 1989 and 2018, 1,162 patients underwent gastrectomy with curative intent for cancer. Median age was 71 years (interquartile range, 63−76 years) and 763 (66%) were male. Patient presentation changed with epigastric discomfort now the most common presentation (67%). An improvement in overall complications from 54% to 35% (P = .006) and mortality from 8% to 1% (P < .001) was seen over the time period and overall survival improved from 28 months to 53 months (P < .001).

      Conclusion

      Both short-term and long-term outcomes have significantly improved over the 30 years studied. The reasons for this are multifactorial and include the use of perioperative chemotherapy, the introduction of an enhanced recovery pathway, and improved preoperative assessment of patients through a multidisciplinary input.
      To read this article in full you will need to make a payment
      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Siegel R.L.
        • Miller K.D.
        • Jemal A.
        Cancer statistics, 2016.
        CA Cancer J Clin. 2016; 66: 7-30
        • Russo A.
        • Li P.
        • Strong V.E.
        Differences in the multimodal treatment of gastric cancer: East versus West.
        J Surg Oncol. 2017; 115: 603-614
        • Hartgrink H.H.
        • van de Velde C.J.H.
        • Putter H.
        • et al.
        Neo-adjuvant chemotherapy for operable gastric cancer: Long term results of the Dutch randomised FAMTX trial.
        Eur J Surg Oncol. 2004; 30: 643-649
        • Schuhmacher C.
        • Gretschel S.
        • Lordick F.
        • et al.
        Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European organisation for research and treatment of cancer randomized trial 40954.
        J Clin Oncol. 2010; 28: 5210-5218
        • Songun I.
        • Putter H.
        • Kranenbarg E.M.K.
        • et al.
        Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
        Lancet Oncol. 2010; 11: 439-449
        • Degiuli M.
        • Sasako M.
        • Ponti A.
        • et al.
        Morbidity and mortality after D2 gastrectomy for gastric cancer: Results of the Italian gastric cancer study group prospective multicenter surgical study.
        J Clin Oncol. 1998; 16: 1490-1493
        • Jiang L.
        • Yang K.H.
        • Chen Y.
        • et al.
        Systematic review and meta-analysis of the effectiveness and safety of extended lymphadenectomy in patients with resectable gastric cancer.
        Br J Surg. 2014; 101: 595-604
        • Degiuli M.
        • Sasako M.
        • Ponti A.
        • et al.
        Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer.
        Br J Surg. 2014; 101: 23-31
        • Wee I.J.Y.
        • Syn N.L.X.
        • Shabbir A.
        • et al.
        Enhanced recovery versus conventional care in gastric cancer surgery: A meta-analysis of randomized and non-randomized controlled trials.
        Gastric Cancer. 2019; 22: 423-434
        • Cunningham D.
        • Allum W.H.
        • Stenning S.P.
        • et al.
        Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.
        N Engl J Med. 2006; 355: 11-20
        • Navidi M.
        • Madhavan A.
        • Griffin S.M.
        • et al.
        Trainee performance in radical gastrectomy and its effect on outcomes.
        BJS Open. 2020; 4: 86-90
        • Mapstone N.
        Dataset for the Histopahtological Reporting of Oesophageal Carcinoma.
        2nd ed. Royal College of Pathologists, London, UK2007
        • Grabsch H.
        • Mapstone N.
        • Novelli M.
        Standards and datasets for reporting cancersDataset for histopathological reporting of oesophageal and gastric carcinoma.
        • Lagarde S.M.
        • Phillips A.W.
        • Navidi M.
        • et al.
        Clinical outcomes and benefits for staging of surgical lymph node mapping after esophagectomy.
        Dis Esophagus. 2017; 30: 1-7
      1. Ajani J, In H, Sano T, Stomach. AJCC Cancer Staging Manual. In: Amin M, Edge S, Greene F, et al, eds. New York: Springer; 2016:203–220.

        • Jung M.R.
        • Park Y.K.
        • Seon J.W.
        • et al.
        Definition and classification of complications of gastrectomy for gastric cancer based on the accordion severity grading system.
        World J Surg. 2012; 36: 2400-2411
        • Strasberg S.M.
        • Linehan D.C.
        • Hawkins W.G.
        The accordion severity grading system of surgical complications.
        Ann Surg. 2009; 250: 177-186
        • Dindo D.
        • Demartines N.
        • Clavien P.-A.
        Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey.
        Ann Surg. 2004; 240: 205-213
        • Kamarajah S.K.
        • Phillips A.W.
        • Hanna G.B.
        • Low D.E.
        • Markar S.R.
        • et al.
        Is Local Endoscopic Resection a Viable Therapeutic Option for Early Clinical Stage T1a and T1b Esophageal Adenocarcinoma?: A Propensity-Matched Analysis. Annals of surgery. 2020..
        Ann Surg. 2020;
        • van der Werf L.R.
        • Busweiler L.A.D.
        • van Sandick J.W.
        • et al.
        Reporting national outcomes after esophagectomy and gastrectomy according to the Esophageal Complications Consensus Group (ECCG).
        Ann Surg. 2020; 271: 1095-1101
        • van Putten M.
        • Nelen S.D.
        • Lemmens V.E.P.P.
        • et al.
        Overall survival before and after centralization of gastric cancer surgery in the Netherlands.
        Br J Surg. 2018; 105: 1807-1815
        • Donohoe C.L.
        • Phillips A.W.
        • Flynn E.
        • et al.
        Multimodal analgesia using intrathecal diamorphine, and paravertebral and rectus sheath catheters are as effective as thoracic epidural for analgesia post-open two-phase esophagectomy within an enhanced recovery program.
        Dis Esophagus. 2018; 31
        • Ng Cheong Chung J.
        • Kamarajah S.
        • Mohammed A.
        • et al.
        Comparison of multimodal analgesia with thoracic epdirual after transthoracic oesophagectomy.
        Br J Surg. 2021; 108: 58-65
        • Kamarajah S.
        • Navidi M.
        • Griffin S.
        • et al.
        Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer.
        Br J Surg. 2020; 107: 1648-1658
        • Saunders J.H.
        • Yanni F.
        • Dorrington M.S.
        • et al.
        Impact of postoperative complications on disease recurrence and long-term survival following oesophagogastric cancer resection.
        Br J Surg. 2020; 107: 103-112
        • Bowrey D.J.
        • Griffin S.M.
        • Wayman J.
        • et al.
        Use of alarm symptoms to select dyspeptics for endoscopy causes patients with curable esophagogastric cancer to be overlooked.
        Surg Endosc. 2006; 20: 1725-1728
        • Petrillo A.
        • Smyth E.C.
        27 years of stomach cancer: Painting a global picture.
        Lancet Gastroenterol Hepatol. 2020; 5: 5-6
        • Chmelo J.
        • Phillips A.W.
        • Greystoke A.
        • et al.
        A feasibility study to investigate the utility of a home-based exercise intervention during and after neo-adjuvant chemotherapy for oesophago-gastric cancer: The ChemoFit study protocol.
        Pilot Feasibility Stud. 2020; 6: 50
        • Bolger J.C.
        • Loughney L.
        • Tully R.
        • et al.
        Perioperative prehabilitation and rehabilitation in esophagogastric malignancies: A systematic review.
        Dis Esophagus. 2020; 6: 50
        • O’Neill L.M.
        • Guinan E.
        • Doyle S.L.
        • et al.
        The RESTORE randomized controlled trial: Impact of a multidisciplinary rehabilitative program on cardiorespiratory fitness in esophagogastric cancer survivorship.
        Ann Surg. 2018; 268: 747-755
        • Li P.
        • Ling Y.-H.
        • Zhu C.-M.
        • et al.
        Vascular invasion as an independent predictor of poor prognosis in nonmetastatic gastric cancer after curative resection.
        Int J Clin Exp Pathol. 2015; 8: 3910-3918
        • Deng J.
        • You Q.
        • Gao Y.
        • et al.
        Prognostic value of perineural invasion in gastric cancer: A systematic review and meta-analysis.
        PLoS One. 2014; 9: e88907
        • Woodham B.L.
        • Chmelo J.
        • Donohoe C.L.
        • et al.
        Prognostic significance of lymphatic, venous and perineural invasion after neoadjuvant chemotherapy in patients with gastric adenocarcinoma.
        Ann Surg Oncol. 2019; 32: doz058
        • Navidi M.
        • Phillips A.W.
        • Griffin S.M.
        • et al.
        Cardiopulmonary fitness before and after neoadjuvant chemotherapy in patients with oesophagogastric cancer.
        Br J Surg. 2018; 105: 900-906
        • Choi Y.Y.
        • Kim H.
        • Shin S.J.
        • et al.
        microsatellite instability and programmed cell death-ligand 1 expression in stage II/III gastric cancer: Post hoc analysis of the CLASSIC randomized controlled study.
        Ann Surg. 2019; 270: 309-316
        • Sultan J.
        • Griffin S.M.
        • Di Franco F.
        • et al.
        Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery.
        Br J Surg. 2012; 99: 346-355
        • Adiamah A.
        • Skořepa P.
        • Weimann A.
        • et al.
        The impact of preoperative immune modulating nutrition on outcomes in patients undergoing surgery for gastrointestinal cancer: A systematic review and meta-analysis.
        Ann Surg. 2019; 270: 247-256
        • Chaudhary A.
        • Domínguez-Muñoz J.E.
        • Layer P.
        • et al.
        Pancreatic exocrine insufficiency as a complication of gastrointestinal surgery and the impact of pancreatic enzyme replacement therapy.
        Dig Dis. 2020; 38: 53-68
        • Heneghan H.M.
        • Zaborowski A.
        • Fanning M.
        • et al.
        Prospective study of malabsorption and malnutrition after esophageal and gastric cancer surgery.
        Ann Surg. 2015; 262: 803-808
        • Honda M.
        • Hiki N.
        • Kinoshita T.
        • et al.
        Long-term outcomes of laparoscopic versus open surgery for clinical stage I gastric cancer: The LOC-1 study.
        Ann Surg. 2016; 264: 214-222
        • Kinoshita T.
        • Uyama I.
        • Terashima M.
        • et al.
        Long-term outcomes of laparoscopic versus open surgery for clinical stage II/III gastric cancer: A multicenter cohort study in Japan (LOC-A study).
        Ann Surg. 2019; 269: 887-894
        • Li Z.
        • Liu Y.
        • Hao Y.
        • et al.
        Surgical and long-term oncologic outcomes of laparoscopic and open gastrectomy for serosa-positive (pT4a) gastric cancer: A propensity score-matched analysis.
        Surg Oncol. 2019; 28: 167-173
        • Shin H.-J.
        • Son S.-Y.
        • Wang B.
        • et al.
        Long-term comparison of robotic and laparoscopic gastrectomy for gastric cancer.
        Ann Surg. 2020; 1
        • Tao M.
        • Zhou X.
        • Hu M.
        • et al.
        Endoscopic submucosal dissection versus endoscopic mucosal resection for patients with early gastric cancer: A meta-analysis.
        BMJ Open. 2019; 9e025803